Up next

Autoplay

Oxybutynin nets dramatic reduction in hot flashes

0 Views • 08/25/25
Share
Side Effects
Side Effects
Subscribers
0

Oxybutynin (Ditropan), a drug approved for the treatment of overactive bladder, provides a new option for managing hot flashes in women who can’t use estrogen because of a history of or concern about breast cancer, suggests a phase 3 double-blind randomized controlled trial reported in a session and press conference at the San Antonio Breast Cancer Symposium.

Show more
0 Comments sort Sort By

Up next

Autoplay